Curaleaf officially opened its second medical cannabis dispensary in Massachusetts.
Located at 425 Main Street, Curaleaf offers a range of innovative cannabis products, sold in a caring and compassionate environment. Curaleaf’s knowledgeable and experienced staff guide patients through the purchasing process, providing private, one-on-one consultation. The Oxford location will also continue to host monthly educational events open to the community to discuss topics such as the medical benefits of CBD and cooking with cannabis. Photos of the Oxford location can be found here.
“Many patients rely on medical cannabis as treatment for multiple conditions including epilepsy, cancer and PTSD,” said Patrik Johnson, Curaleaf President. “Before our Oxford location opened, many of these patients had to drive significant distances in order to purchase a needed medical aid. Curaleaf’s Oxford dispensary will make medical cannabis more accessible and provide patients with the most reliable and high-quality product on the market.”
The official opening was marked by a ribbon cutting joined by Selectman John Saad and Canna Care Docs.
“Safe access to Cannabis medicine is now available to residents of central Mass, and other Massachusetts medical Cannabis card holders,” said Kathleen McKinnon, Director of Operations for Canna Care Docs. “Canna Care Docs has educated and certified thousands of patients over the last 5 years. We have seen patients achieve relief and wellness with the opportunity to access medicine that has been lab tested and safely processed for consumption.”
Curaleaf is one of the largest medical cannabis dispensaries in the country, operating across multiple states. As a leading brand, Curaleaf prides itself on its customer service and premium products trusted by thousands of patients. To learn more about Curaleaf’s growing network of dispensaries visit www.curaleaf.com.
About Curaleaf
Led by a team of physicians, pharmacists, medical experts and industry visionaries, Curaleaf develops safe, effective, and innovative cannabis-based therapeutic products. Curaleaf combines the industry’s most medically precise and technologically advanced production techniques in order to deliver consistent, high-quality products that patients and health care professionals can trust. Based on a foundation of compassion, professionalism and respect, Curaleaf strives to empower health care professionals and patients by providing product expertise and guidance to help them make the right choices. Curaleaf is committed to being the industry’s leading resource in education and advancement of medical cannabis through research and advocacy. Currently, Curaleaf manages multiple dispensaries across five states. More information regarding Curaleaf can be found at www.curaleaf.com.
